Home > Quotes > XPH

SPDR S&P Pharmaceuticals ETF Stock Quote & Summary Data

(ETF)
XPH 
$114.14
*  
1.83
1.63%
Get XPH Alerts
*Delayed - data as of Jan. 29, 2015  -  Find a broker to begin trading XPH now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks
1 Year Target
Today's High /Low  / 
Share Volume
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 116,170
Previous Close $ 112.31
52 Week High/Low $ 116.66 / $ 85.28
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 1,090,037,000
Annualized dividend $ 21.9471
Ex Dividend Date Dec. 19, 2014
Dividend Payment Date Dec. 30, 2014
Current Yield 19.54 %
Beta 0

Intraday Chart

Description

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Pharmaceuticals Select Industry Index. The Index represents the pharmaceuticals sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards. Membership in the Select Industry Indexes is based on the GICS classification, as well as liquidity and market cap requirements. Companies in the Select Industry Indexes are classified based primarily on revenues; however, earnings and market perception are also considered. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.


Underlying Index S&P Pharmaceuticals Select Industry Index
Management Fee 0.35
Asset Class Equity
Leverage 1

News for XPH

Top Holdings
THRX Theravance 3.58%
AKRX Akorn Inc 3.44%
SLXP Salix Pharmaceuticals 3.44%
PCRX Pacira Pharmaceuticals 3.32%
ACT Actavis Inc 3.31%
FRX Forest Laboratories 3.26%
IPXL Impax Laboratories 3.26%
LLY Eli Lilly and Company 3.24%
JAZZ Jazz Pharmaceuticals 3.22%
HZNP Horizon Pharma Inc 3.2%

Research Brokers before you trade

Want to trade FX?